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The epithelial-to-mesenchymal transition (EMT) is a cel-
lular dedifferentiation process that is critical to develop-
ment, wound healing and metastasis. Like other cell state
transitions, such as differentiation, EMT is accompanied
by genome-wide epigenetic reprogramming. However,
the relationship between reprogramming and functional
changes in the cell is poorly understood. In an A549
non-small cell lung cancer EMT model system we
observed changes in chromatin state between epithelial
and mesenchymal states. Multivariate analyses were
applied to paired (epithelial and mesenchymal) ChIP-seq
data for 18 histone modifications/variants and expression
microarray data. We observed epigenetic co-regulation of
genes associated with EMT, as well as their proximal
enhancers. We also observed epigenetic activation or
repression of functionally distinct sets of enhancers.
These genes and enhancers are regulated and bound by a
small set of transcription factors, specifically AP-1, NF-
B and c-Myc. These transcription factors themselves
also a show an epigenetic profile similar to the EMT-
related genes. Together, these observations suggest a
chromatin-mediated transcriptional feedback mechanism
that establishes and maintains the phenotypic switch.
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